866-997-4948(US-Canada Toll Free)

Global Gastrointestinal Drugs Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Sep 2018

Category :

Pharmaceutical

No. of Pages : 119 Pages

This report studies the global market size of Gastrointestinal Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Gastrointestinal Drugs in these regions.
This research report categorizes the global Gastrointestinal Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
In 2017, the global Gastrointestinal Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Gastrointestinal Drugs market based on company, product type, application and key regions.

The various contributors involved in the value chain of Gastrointestinal Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Gastrointestinal Drugs include
AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
ZeriaTillotts
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen

Market Size Split by Type
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Market Size Split by Application
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Gastrointestinal Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Gastrointestinal Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Gastrointestinal Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gastrointestinal Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Gastrointestinal Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Gastrointestinal Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Gastrointestinal Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Gastrointestinal Drugs Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Gastrointestinal Drugs Market Size Growth Rate by Type
1.4.2 Prescription Gastrointestinal Drug
1.4.3 OTC Gastrointestinal Drug
1.5 Market by Application
1.5.1 Global Gastrointestinal Drugs Market Size Growth Rate by Application
1.5.2 Chronic Gastritis
1.5.3 Functional Dyspepsia
1.5.4 Peptic Ulcer
1.5.5 Acute Gastroenteritis
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Gastrointestinal Drugs Market Size
2.1.1 Global Gastrointestinal Drugs Revenue 2016-2025
2.1.2 Global Gastrointestinal Drugs Sales 2016-2025
2.2 Gastrointestinal Drugs Growth Rate by Regions
2.2.1 Global Gastrointestinal Drugs Sales by Regions
2.2.2 Global Gastrointestinal Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Gastrointestinal Drugs Sales by Manufacturers
3.1.1 Gastrointestinal Drugs Sales by Manufacturers
3.1.2 Gastrointestinal Drugs Sales Market Share by Manufacturers
3.1.3 Global Gastrointestinal Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Gastrointestinal Drugs Revenue by Manufacturers
3.2.1 Gastrointestinal Drugs Revenue by Manufacturers (2016-2018)
3.2.2 Gastrointestinal Drugs Revenue Share by Manufacturers (2016-2018)
3.3 Gastrointestinal Drugs Price by Manufacturers
3.4 Gastrointestinal Drugs Manufacturing Base Distribution, Product Types
3.4.1 Gastrointestinal Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastrointestinal Drugs Product Category
3.4.3 Date of International Manufacturers Enter into Gastrointestinal Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Gastrointestinal Drugs Sales by Type
4.2 Global Gastrointestinal Drugs Revenue by Type
4.3 Gastrointestinal Drugs Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Gastrointestinal Drugs Breakdown Data by Application

6 North America
6.1 North America Gastrointestinal Drugs by Countries
6.1.1 North America Gastrointestinal Drugs Sales by Countries
6.1.2 North America Gastrointestinal Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Gastrointestinal Drugs by Type
6.3 North America Gastrointestinal Drugs by Application
6.4 North America Gastrointestinal Drugs by Company

7 Europe
7.1 Europe Gastrointestinal Drugs by Countries
7.1.1 Europe Gastrointestinal Drugs Sales by Countries
7.1.2 Europe Gastrointestinal Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gastrointestinal Drugs by Type
7.3 Europe Gastrointestinal Drugs by Application
7.4 Europe Gastrointestinal Drugs by Company

8 Asia Pacific
8.1 Asia Pacific Gastrointestinal Drugs by Countries
8.1.1 Asia Pacific Gastrointestinal Drugs Sales by Countries
8.1.2 Asia Pacific Gastrointestinal Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Gastrointestinal Drugs by Type
8.3 Asia Pacific Gastrointestinal Drugs by Application
8.4 Asia Pacific Gastrointestinal Drugs by Company

9 Central & South America
9.1 Central & South America Gastrointestinal Drugs by Countries
9.1.1 Central & South America Gastrointestinal Drugs Sales by Countries
9.1.2 Central & South America Gastrointestinal Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Gastrointestinal Drugs by Type
9.3 Central & South America Gastrointestinal Drugs by Application
9.4 Central & South America Gastrointestinal Drugs by Company

10 Middle East and Africa
10.1 Middle East and Africa Gastrointestinal Drugs by Countries
10.1.1 Middle East and Africa Gastrointestinal Drugs Sales by Countries
10.1.2 Middle East and Africa Gastrointestinal Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Gastrointestinal Drugs by Type
10.3 Middle East and Africa Gastrointestinal Drugs by Application
10.4 Middle East and Africa Gastrointestinal Drugs by Company

11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Gastrointestinal Drugs
11.1.4 Gastrointestinal Drugs Product Description
11.1.5 Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Gastrointestinal Drugs
11.2.4 Gastrointestinal Drugs Product Description
11.2.5 Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Gastrointestinal Drugs
11.3.4 Gastrointestinal Drugs Product Description
11.3.5 Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Gastrointestinal Drugs
11.4.4 Gastrointestinal Drugs Product Description
11.4.5 Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Gastrointestinal Drugs
11.5.4 Gastrointestinal Drugs Product Description
11.5.5 Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Gastrointestinal Drugs
11.6.4 Gastrointestinal Drugs Product Description
11.6.5 Recent Development
11.7 ZeriaTillotts
11.7.1 ZeriaTillotts Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Gastrointestinal Drugs
11.7.4 Gastrointestinal Drugs Product Description
11.7.5 Recent Development
11.8 Perrigo
11.8.1 Perrigo Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Gastrointestinal Drugs
11.8.4 Gastrointestinal Drugs Product Description
11.8.5 Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Gastrointestinal Drugs
11.9.4 Gastrointestinal Drugs Product Description
11.9.5 Recent Development
11.10 Purdue Pharma
11.10.1 Purdue Pharma Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Gastrointestinal Drugs
11.10.4 Gastrointestinal Drugs Product Description
11.10.5 Recent Development
11.11 C.B. Fleet
11.12 Abbott
11.13 Jiangzhong
11.14 Xian-Janssen

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Gastrointestinal Drugs Raw Material
13.1.2 Gastrointestinal Drugs Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Gastrointestinal Drugs
Figure Global Gastrointestinal Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Gastrointestinal Drugs Production Market Share by Types (Product Category) in 2017
Figure Prescription Gastrointestinal Drug Product Picture
Table Major Manufacturers of Prescription Gastrointestinal Drug
Figure OTC Gastrointestinal Drug Product Picture
Table Major Manufacturers of OTC Gastrointestinal Drug
Table Global Gastrointestinal Drugs Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Chronic Gastritis
Figure Functional Dyspepsia
Figure Peptic Ulcer
Figure Acute Gastroenteritis
Figure Other
Figure Gastrointestinal Drugs Report Years Considered
Figure Global Gastrointestinal Drugs Market Size 2016-2025 (Million US$)
Figure Global Gastrointestinal Drugs Sales 2016-2025 (K Units)
Table Global Gastrointestinal Drugs Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Gastrointestinal Drugs Sales by Regions 2016-2025 (K Units)
Table Global Gastrointestinal Drugs Sales Market Share by Regions 2016-2025
Figure Global Gastrointestinal Drugs Sales Market Share by Regions 2016-2025
Figure 2017 Global Gastrointestinal Drugs Sales Market Share by Regions
Table Global Gastrointestinal Drugs Revenue by Regions 2016-2025 (Million US$)
Table Global Gastrointestinal Drugs Revenue Market Share by Regions 2016-2025
Figure Global Gastrointestinal Drugs Revenue Market Share by Regions 2016-2025
Figure 2017 Global Gastrointestinal Drugs Revenue Market Share by Regions
Table Global Gastrointestinal Drugs Sales by Manufacturers (2016-2018) (K Units)
Table Global Gastrointestinal Drugs Sales Share by Manufacturers (2016-2018)
Figure Global Gastrointestinal Drugs Sales Share by Manufacturers in 2017
Table Gastrointestinal Drugs Revenue by Manufacturers (2016-2018) (Million US$)
Table Gastrointestinal Drugs Revenue Share by Manufacturers (2016-2018)
Figure Gastrointestinal Drugs Value Share by Manufacturers in 2017
Table Global Gastrointestinal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Gastrointestinal Drugs Price (2016-2018) (USD/Unit)
Table Gastrointestinal Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Gastrointestinal Drugs Product Category
Table Date of International Manufacturers Enter into Gastrointestinal Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Gastrointestinal Drugs Sales by Type (2016-2025) (K Units)
Table Global Gastrointestinal Drugs Sales Share by Type (2016-2025)
Figure Global Gastrointestinal Drugs Sales Market Share by Type (2016-2025)
Figure Global Gastrointestinal Drugs Sales Market Share by Type in 2017
Table Global Gastrointestinal Drugs Revenue by Type (2016-2025) (Million US$)
Table Global Gastrointestinal Drugs Revenue Share by Type (2016-2025)
Figure Global Gastrointestinal Drugs Revenue Market Share by Type (2016-2025)
Figure Global Gastrointestinal Drugs Revenue Market Share by Type in 2017
Table Gastrointestinal Drugs Price by Type 2013-2018 (USD/Unit)
Table Global Gastrointestinal Drugs Sales by Application (2016-2025) (K Units)
Table Global Gastrointestinal Drugs Sales Share by Application (2016-2025)
Figure Global Sales Gastrointestinal Drugs Market Share by Application (2016-2025)
Figure Global Sales Gastrointestinal Drugs Market Share by Application (2016-2025)
Figure North America Gastrointestinal Drugs Sales Growth Rate 2016-2025 (K Units)
Figure North America Gastrointestinal Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table North America Gastrointestinal Drugs Sales by Countries (2016-2025) (K Units)
Table North America Gastrointestinal Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 North America Gastrointestinal Drugs Sales Market Share by Countries
Table North America Gastrointestinal Drugs Revenue by Countries (2016-2025) (Million US$)
Table North America Gastrointestinal Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Gastrointestinal Drugs Revenue Market Share by Countries
Figure United States Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure United States Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Canada Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table North America Gastrointestinal Drugs Sales by Type (2016-2025) (K Units)
Table North America Gastrointestinal Drugs Sales Market Share by Type (2016-2025)
Figure 2017 North America Gastrointestinal Drugs Market Share by Type
Table North America Gastrointestinal Drugs Sales by Application (2016-2025) (K Units)
Table North America Gastrointestinal Drugs Sales Market Share by Application (2016-2025)
Figure 2017 North America Gastrointestinal Drugs Market Share by Application
Table North America Gastrointestinal Drugs Sales by Company (2016-2018) (K Units)
Table North America Gastrointestinal Drugs Sales Market Share by Company (2016-2018)
Figure North America Gastrointestinal Drugs Sales Market Share by Company in 2017
Figure Europe Gastrointestinal Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Europe Gastrointestinal Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Gastrointestinal Drugs Sales by Countries (2016-2025) (K Units)
Table Europe Gastrointestinal Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Gastrointestinal Drugs Sales Market Share by Countries
Table Europe Gastrointestinal Drugs Revenue by Countries (2016-2025) (Million US$)
Table Europe Gastrointestinal Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Gastrointestinal Drugs Revenue Market Share by Countries
Figure Germany Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Germany Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (K Units)
Figure France Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure France Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (K Units)
Figure UK Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure UK Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Italy Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Russia Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Gastrointestinal Drugs Sales by Type (2016-2025) (K Units)
Table Europe Gastrointestinal Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Europe Gastrointestinal Drugs Market Share by Type
Table Europe Gastrointestinal Drugs Sales by Application (2016-2025) (K Units)
Table Europe Gastrointestinal Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Europe Gastrointestinal Drugs Market Share by Application
Table Europe Gastrointestinal Drugs Sales by Company (2016-2018) (K Units)
Table Europe Gastrointestinal Drugs Sales Market Share by Company (2016-2018)
Figure Europe Gastrointestinal Drugs Sales Market Share by Company in 2017
Figure Asia Pacific Gastrointestinal Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Gastrointestinal Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Gastrointestinal Drugs Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Gastrointestinal Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Gastrointestinal Drugs Sales Market Share by Countries
Table Asia Pacific Gastrointestinal Drugs Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Gastrointestinal Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Gastrointestinal Drugs Revenue Market Share by Countries
Figure China Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure China Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Japan Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Korea Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure India Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure India Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Australia Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Gastrointestinal Drugs Sales by Type (2016-2025) (K Units)
Table Asia Pacific Gastrointestinal Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Gastrointestinal Drugs Market Share by Type
Table Asia Pacific Gastrointestinal Drugs Sales by Application (2016-2025) (K Units)
Table Asia Pacific Gastrointestinal Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Gastrointestinal Drugs Market Share by Application
Table Asia Pacific Gastrointestinal Drugs Sales by Company (2016-2018) (K Units)
Table Asia Pacific Gastrointestinal Drugs Sales Market Share by Company (2016-2018)
Figure Asia Pacific Gastrointestinal Drugs Sales Market Share by Company in 2017
Figure Central & South America Gastrointestinal Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Gastrointestinal Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Gastrointestinal Drugs Sales by Countries (2016-2025) (K Units)
Table Central & South America Gastrointestinal Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Gastrointestinal Drugs Sales Market Share by Countries
Table Central & South America Gastrointestinal Drugs Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Gastrointestinal Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Gastrointestinal Drugs Revenue Market Share by Countries
Figure Brazil Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Gastrointestinal Drugs Sales by Type (2016-2025) (K Units)
Table Central & South America Gastrointestinal Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Gastrointestinal Drugs Market Share by Type
Table Central & South America Gastrointestinal Drugs Sales by Application (2016-2025) (K Units)
Table Central & South America Gastrointestinal Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Gastrointestinal Drugs Market Share by Application
Table Central & South America Gastrointestinal Drugs Sales by Company (2016-2018) (K Units)
Table Central & South America Gastrointestinal Drugs Sales Market Share by Company (2016-2018)
Figure Central & South America Gastrointestinal Drugs Sales Market Share by Company in 2017
Figure Middle East and Africa Gastrointestinal Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Gastrointestinal Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Gastrointestinal Drugs Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Gastrointestinal Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Gastrointestinal Drugs Sales Market Share by Countries
Table Middle East and Africa Gastrointestinal Drugs Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Gastrointestinal Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Gastrointestinal Drugs Revenue Market Share by Countries
Figure GCC Countries Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Gastrointestinal Drugs Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Gastrointestinal Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Gastrointestinal Drugs Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Gastrointestinal Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Gastrointestinal Drugs Market Share by Type
Table Middle East and Africa Gastrointestinal Drugs Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Gastrointestinal Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Gastrointestinal Drugs Market Share by Application
Table Middle East and Africa Gastrointestinal Drugs Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Gastrointestinal Drugs Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Gastrointestinal Drugs Sales Market Share by Company in 2017
Table AstraZeneca Company Details
Table AstraZeneca Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table AstraZeneca Recent Development
Table Sanofi Company Details
Table Sanofi Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Bayer Company Details
Table Bayer Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Bayer Recent Development
Table Pfizer Company Details
Table Pfizer Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GlaxoSmithKline Recent Development
Table Teva Company Details
Table Teva Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Teva Recent Development
Table ZeriaTillotts Company Details
Table ZeriaTillotts Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table ZeriaTillotts Recent Development
Table Perrigo Company Details
Table Perrigo Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Perrigo Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Boehringer Ingelheim Recent Development
Table Purdue Pharma Company Details
Table Purdue Pharma Gastrointestinal Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Purdue Pharma Recent Development
Table C.B. Fleet Company Details
Table Abbott Company Details
Table Jiangzhong Company Details
Table Xian-Janssen Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Gastrointestinal Drugs Value Chain
Table Typical Suppliers of Key Gastrointestinal Drugs Raw Material
Table Gastrointestinal Drugs Customers List
Table Gastrointestinal Drugs Sales Channels
Table Gastrointestinal Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *